ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

Stop Cancer Still Working To Raise Funds

March 22, 1991

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

October issue of Business & Regulatory Report included.

November 5, 2004

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010